3M exits pharma
The diversified industrial firm divests its pharmaceutical business in a three-way deal for approximately $2.1 bil. Under the deal, announced Nov. 9, Graceway acquires 3M's North and South American operations for $875 mil., Meda AB acquires the European business for $857 mil., and Ironbridge Capital and Archer Capital net the Asia Pacific region for $349 mil. 3M's pharma portfolio includes Aldara, Tambocor, Minitran and Maxair Autohaler...
You may also be interested in...
DJO Global will buy Trilliant Surgical to further its ongoing expansion into the US foot and ankle market.
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.